Amrize financials
$37.71−0.89%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 |
|---|---|
| Revenue | $11.81B |
| Gross profit | $3.03B |
| Gross margin | 25.7% |
| Operating income | $1.91B |
| Net income | $1.19B |
| Net margin | 10.0% |
| Diluted EPS | $2.14 |
| EBITDA | $2.82B |
| Operating cash flow | $2.21B |
| Free cash flow | $1.42B |
| Diluted shares | 553.6M |
Balance sheet
| Period end | Dec 31 |
|---|---|
| Cash & equivalents | $1.92B |
| Short-term investments | $0.00 |
| Total debt | $5.27B |
| Total assets | $24.21B |
| Total liabilities | $11.09B |
| Shareholders' equity | $13.12B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology